Tiny implants signal new way to treat cancer tumors

March 14, 2013

Cancer patients could be treated more effectively in future with tiny, sensory implants that will monitor tumours in real time and in great detail.

The devices, about the size of an eyelash, would be implanted into patients' tumours. They would allow doctors to target radiotherapy, and ultimately chemotherapy, where and when it is most needed, improving patients' chances of recovery.

The devices will be designed to measure directly vital factors about tumours, such as their levels of and key , transmitting the information wirelessly to medical staff. These readings would enable doctors to identify and target areas of a tumour that are found to be resistant to radiotherapy and drug treatment.

Sensors would also take measurements to indicate how effective the treatment is in killing , enabling therapy to be personalised to an individual patient's cancer. Doctors would be able to monitor patients' progress with an unprecedented level of detail.

A team led by the University of Edinburgh, in collaboration with Heriot-Watt University, will develop the miniature chips in a five-year project to prove the technology, which they hope to follow with clinical trials.

The team also hopes eventually to develop chips that are capable of delivering doses of chemotherapy directly to a .

The £5.2 million project, Implantable Microsystems for Personalised Anti- (IMPACT), is funded by the Engineering and Physical Sciences Research Council.

Professor Alan Murray of the University of Edinburgh, who is leading the study, said: "Experts including scientists, engineers, clinicians and social scientists will be working to target cancer, one of the biggest health concerns of today, in an entirely new way. Our aim is, in the long term, help to alleviate suffering and to improve the outlook for very many ."

Explore further: Drug shrinks lung cancer tumors in mice

Related Stories

Drug shrinks lung cancer tumors in mice

November 10, 2009

(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer tumours from growing ...

Bone cancer, from the lab to the clinic

June 8, 2011

A new study into osteosarcoma - cancer of the bone - will use advances in genomic research and analysis to identify new genes that give rise to the condition and to create personalised blood tests for children and young adults ...

Scientists reveal best imaging technique for ovarian cancer

February 15, 2012

Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ...

Recommended for you

Oxygen can impair cancer immunotherapy in mice

August 25, 2016

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer ...

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells - special cells that divide to repair and generate tissues - might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.